Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
GLP-1 space will remain two player over the medium to long term, says Mizuho's Jared Holz
06:21pm, Friday, 28'th Mar 2025
Jared Holz, Mizuho, joins 'Closing Bell Overtime' to talk Novo Nordisk sinking on lighter-than-expected GLP-1 demand.
Here's one healthcare name this strategist says is buy, and another to avoid
05:40pm, Friday, 28'th Mar 2025
In the latest Good Buy or Goodbye, Regan Capital chief investment officer Skyler Weinand joins Market Domination host Julie Hyman to break down which stock is a good buy and what stock should be avoid
CHMP Recommends Against Approval of Eli Lilly's Kisunla Alzheimer's Drug -- Update
11:45am, Friday, 28'th Mar 2025
A key European regulatory committee has recommended against approval of Eli Lilly's Kisunla, saying the benefits of the Alzheimer's disease drug don't outweigh its risks.
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Friday, 28'th Mar 2025
Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
EU medicines regulator rejects Eli Lilly's Alzheimer's drug
06:56am, Friday, 28'th Mar 2025
The European Union's drugs regulator on Friday rejected Eli Lilly's Alzheimer's drug Kisunla, saying the risk of serious brain swelling did not outweigh the treatment's small impact on slowing cogniti
When looking for investment inspiration, it's a great idea to consider what some of the world's most successful investors are doing. Each one of their moves may not be right for your particular invest
VIG: Index Rebalance Adds Eli Lilly To Bolster Dividend Growth In 2025
08:39pm, Thursday, 27'th Mar 2025
VIG's Index rebalanced last week and now counts Eli Lilly as its #5 holding with a 3.45% allocation. The ETF is on an impressive 11-year dividend growth streak. The Index yield dropped 0.04% to 1.81%,
Beyond GLP-1 Drugs: This Opportunity at Eli Lilly Could Surprise Everyone in 2025
09:15am, Thursday, 27'th Mar 2025
Over the last couple of years, the pharmaceutical sector has captivated investors thanks in large part to novel medications used to treat chronic weight management and diabetes.
Lilly adds Alzheimer's to online offerings
09:01am, Thursday, 27'th Mar 2025
Eli Lilly on Thursday expanded its direct-to-consumer online platform LillyDirect to include telehealth providers to diagnose and care for patients with Alzheimer's disease, potentially boosting sales
Price Targets Show These 3 Stocks Near the $1 Trillion Mark
07:31am, Thursday, 27'th Mar 2025
Currently, just eight vaunted stocks boast market capitalizations of over $1 trillion. This includes six of the Magnificent Seven stocks, as well as Warren Buffett's Berkshire Hathaway NYSE: BRK.A.
Checking in on the weight-loss drug space: Novo Nordisk, Eli Lilly, and others
05:58pm, Wednesday, 26'th Mar 2025
Eli Lilly (LLY) will soon be releasing trial data on its small-molecule GLP-1 weight-loss pill, Orforglipron. The drug could be pivotal for the obesity treatment market due to its accessibility.
Eli Lilly, Palo Alto Networks Traders Take Note: Direxion's New Leveraged ETFs Are Here
09:25am, Wednesday, 26'th Mar 2025
Active traders have new, highly powered tools at their disposal as Direxion rolls out four single-stock leveraged and inverse exchange-traded funds.
Eli Lilly, Palo Alto Networks Traders Take Note: Direxion's New Leveraged ETFs Are Here
09:25am, Wednesday, 26'th Mar 2025
Active traders have new, highly powered tools at their disposal as Direxion rolls out four single-stock leveraged and inverse exchange-traded funds.
2 No-Brainer Growth Stocks to Buy and Hold Forever
06:05am, Wednesday, 26'th Mar 2025
Don't let market volatility convince you otherwise: Investing in stocks remains one of the best ways to accumulate capital over long periods. It can be hard to remember that when equities are falling,
Eli Lilly (LLY) Stock Sinks As Market Gains: Here's Why
06:50pm, Tuesday, 25'th Mar 2025
Eli Lilly (LLY) closed at $852.35 in the latest trading session, marking a -1.45% move from the prior day.
